Targeted temperature management has become a mainstay of treatment for resuscitated patients following cardiac arrest. Manoj Saxena is an intensivist and clinician researcher from Sydney, Australia, and was part of the team that delivered the TTM-2 trial earlier in 2021.  He joins Todd on the podcast to discuss the premise of TTM-2, the results and what comes next.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Targeted temperature management has become a mainstay of treatment for resuscitated patients following cardiac arrest. Manoj Saxena is an intensivist and clinician researcher from Sydney, Australia, and was part of the team that delivered the TTM-2 trial earlier in 2021. He joins Todd on the podcast to discuss the premise of TTM-2, the results and what comes next. See omnystudio.com/listener for privacy information.

Targeted temperature management has become a mainstay of treatment for resuscitated patients following cardiac arrest. Manoj Saxena is an intensivist and clinician researcher from Sydney, Australia, and was part of the team that delivered the TTM-2 trial earlier in 2021. &nbsp;He joins Todd on the podcast to discuss the premise of TTM-2, the results and what comes next.See <a href="https://omnystudio.com/listener" rel="noopener noreferrer">omnystudio.com/listener</a> for privacy information.

Targeted temperature management

This podcast is dedicated to the hard-working doctors, nurses and allied health professionals striving for excellence

Share Targeted temperature management

Sign up to save your podcasts

Targeted temperature management

Targeted temperature management